Patty sits down with John Hubbard, Strategic Healthcare Advisor, Board Member, and former CEO and President of multiple organizations across pharma and CROs. John shares a candid perspective on why the clinical trials industry continues to struggle with change adoption and innovation.

From leading large-scale transformations at Pfizer to driving industry-wide collaboration through initiatives like TransCelerate, John reflects on the cultural and structural barriers that make progress difficult. He also offers advice to entrepreneurs and innovators trying to break through and why real change often takes a combination of vision, resilience, and a willingness to challenge the status quo.